Contrary to the common worry, it seems that GLP-1 Drugs Like Ozempic might actually be Tied to Lower Risk of Serious Blood Clots
Contrasting with these growth-inhibitory actions of IGFBPs, there is also clear evidence of growth promotion by IGFBPs in both cancer and non-cancer cells, as well as extensive clinical data linking high IGFBP expression in a variety of cancers to a more aggressive phenotype and poor patient survival [17]
Q: When will I see possible outcomes
Enabling studies of GH-driven osteoblast activation, bone formation, IGF-1-mediated skeletal anabolic biology, and growth plate biology without the cortisol-mediated catabolic bone effects that complicate GHRP-6 and GHRP-2 bone biology research
Since then, research has continued, leading to newer, often more effective, and longer-acting versions